Mohammad Zulkernine and John Allingham are Queen’s most recent Canada Research Chairs (CRC).

Dr. Zulkernine (School of Computing), Canada Research Chair in Software Dependability, is investigating a variety of methods and tools for building reliable and secure software systems.

“I am honoured by the appointment,” he says. “It will help me and my students enrich the already-excellent software engineering research in the School of Computing by addressing the challenges in making software more dependable.”

Dr. Allingham (Biomedical and Molecular Sciences), Canada Research Chair in Structural Biology, is working on developing new drug compounds that will specifically inhibit the ability of disease-causing cells to invade our bodies.

“I feel incredibly grateful and privileged to hold a place among some of the greatest scientists and innovators in Canada,” says Dr. Allingham. “I am also very proud to work in the company of the stellar basic and clinical science community at Queen's, and to have the amazing opportunity to explore novel ways to inhibit the invasive properties of cancer cells and microbial pathogens.”

“Having two professors from Queen’s University named as Canada Research Chairs in these areas of research is important. Software security and anti-cancer drugs are crucial to securing safe and successful communities and improving health outcomes. These are examples where Queen’s leads in addressing the most challenging and complex problems facing the world today” says Dr. Steven Liss, Vice-Principal (Research).

In total, $124.5 million is being allocated among 132 Canada Research Chairs to undertake new, cutting-edge research at 36 Canadian postsecondary institutions.